Cigna Group $CI Shares Sold by Turtle Creek Wealth Advisors LLC

24 Apr 2026, 08:54 by Scott Moore · The Cerbat Gem

Turtle Creek Wealth Advisors LLC trimmed its holdings in Cigna Group (NYSE:CI – Free Report) by 15.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,108 shares of the health services provider’s stock after selling 3,337 shares during the quarter. Turtle Creek Wealth Advisors LLC’s holdings in Cigna Group were worth $4,984,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CI. OLD National Bancorp IN grew its position in shares of Cigna Group by 3.7% during the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after acquiring an additional 37 shares during the last quarter. B. Metzler seel. Sohn & Co. AG grew its position in shares of Cigna Group by 28.2% during the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 28,150 shares of the health services provider’s stock worth $7,748,000 after acquiring an additional 6,191 shares during the last quarter. Teacher Retirement System of Texas grew its position in shares of Cigna Group by 5.8% during the fourth quarter. Teacher Retirement System of Texas now owns 235,903 shares of the health services provider’s stock worth $64,928,000 after acquiring an additional 12,926 shares during the last quarter. Mystic Asset Management Inc. grew its position in shares of Cigna Group by 1.4% during the fourth quarter. Mystic Asset Management Inc. now owns 10,191 shares of the health services provider’s stock worth $2,805,000 after acquiring an additional 136 shares during the last quarter. Finally, Joseph P. Lucia & Associates LLC purchased a new position in shares of Cigna Group during the fourth quarter worth approximately $282,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Price Performance

Shares of NYSE CI opened at $279.57 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The stock has a fifty day moving average price of $274.82 and a 200 day moving average price of $277.63. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a market cap of $73.67 billion, a PE ratio of 12.60, a P/E/G ratio of 0.95 and a beta of 0.26.

Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. During the same period last year, the company earned $6.64 earnings per share. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts forecast that Cigna Group will post 30.32 EPS for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on CI shares. Piper Sandler lowered their target price on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Sanford C. Bernstein upgraded shares of Cigna Group from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $307.00 to $358.00 in a research report on Thursday, March 12th. TD Cowen raised their target price on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Jefferies Financial Group lowered their target price on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday. Finally, Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $332.47.

View Our Latest Stock Analysis on CI

Insiders Place Their Bets

In other news, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.60% of the company’s stock.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.